Перетягніть, щоб змінити положення кришки
https://www.selleckchem.com/pr....oducts/otub2-in-1.ht
Genetic modification of T lymphocytes is a key issue in research and therapy. Conventional lentiviral vectors (LVs) are neither selective for T cells nor do they modify resting or minimally stimulated cells, which is crucial for applications, such as efficient in vivo modification of T lymphocytes. Here, we introduce novel CD3-targeted LVs (CD3-LVs) capable of genetically modifying human T lymphocytes without prior activation. For CD3 attachment, agonistic CD3-specific single-chain variable fragments were chosen. Activation, prolifer
Подобається
Не подобається
коментар
Поділіться
Завантажити більше дописів
друзі
1
